Navigation Links
Recalled ICD leads fail in women, youths most often
Date:1/31/2011

The recalled Sprint Fidelis implantable cardioverter-defibrillator (ICD) leads (Medtronic) failed more often in younger patients, women, and individuals with hereditary heart disease, according to a multicenter study published online Jan. 17 in Circulation. The researchers found that lead failure was not associated with death or serious injuries.

However, about half of the patients whose leads fractured experienced painful inappropriate shocks, according to lead author Robert G. Hauser, MD, of the Minneapolis Heart Institute at Abbott Northwestern Hospital. In a previous study, published in HeartRhythm in 2010, Hauser and colleagues found these inappropriate shocks could be mitigated by a software program available in Medtronic ICDs.

The manufacturer voluntarily removed Sprint Fidelis leads from the market in 2007 after 268,000 were implanted globally. Currently, more than 100,000 patients have Fidelis leads.

In this observational study, 1,023 Fidelis and 1,668 Quattro leads were implanted and followed at three centers (Minneapolis Heart Institute in Minneapolis, Mayo Clinic in Rochester, Minn., and Beth Israel Deaconess Medical Center in Boston) from November 2001 to January 2009

"We were particularly interested in whether Fidelis leads were continuing to fail, in whom they were failing and what the implications might be for those patients," Hauser says. "We found that patients who were young and active with relatively normal pump function were at highest risk, as well as women compared with men."

The researchers found the failure rate for Fidelis leads was 2.81 percent per year, compared with 0.43 percent per year for Quattro Secure leads, also manufactured by Medtronic.. The authors described the Quattro failure rate as being "well below the suggested benchmark of 0.6 percent per year. The survival of Fidelis leads at four years was 87 percent, compared with 98.7 percent for Quattro leads

These findings could have significant implications for the management of patients who have Fidelis leads. While Fidelis continue to fail, Hauser and his colleagues conclude that there is currently no indication for arbitrarily replacing leads in patients who were indicated for ICDs, particularly due to the potential risk with the replacement procedures.

"Only in the hands of experienced operators should Fidelis lead replacement even be considered in these younger patients or women, who are expected to live with an ICD for a number of years," Hauser stresses.


'/>"/>

Contact: Meghan Bethke
mbethke@mhif.org
612-863-5410
Minneapolis Heart Institute Foundation
Source:Eurekalert

Related medicine news :

1. FDA Found Bacteria in Ingredients for Recalled Tylenol, Benadryl
2. Learning Lab of Brentwood Leads Free ADHD Seminar
3. Human Dental Technology Leads to Breakthroughs for Pet Dental Health at Sergeants Pet Care Products, Inc.
4. TechCFO Enters Mid-Atlantic Market; Rick Rolandi Leads DC Metro Office
5. Home Health Agency Owner Pleads Guilty in Connection with Detroit Fraud Scheme
6. New DNA technique leads to a breakthrough in child cancer research
7. AGA leads the way in GI innovation
8. Arsenic exposure activates an oncogenic signaling pathway; leads to increased cancer risk
9. KV Pharmaceutical Subsidiary Pleads Guilty to Two Felonies Regarding Oversized Drugs
10. China's Forbidden City Leads Landmark Climate Action for Earth Hour
11. McMaster researcher leads development of promising drug for inflammation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/20/2017)... ... February 20, 2017 , ... ... as an employee health benefit for companies that want to help members of ... providers, employees will have access to Watson’s suite of oncology offerings for insights ...
(Date:2/20/2017)... Orlando, FL (PRWEB) , ... February 20, 2017 ... ... company for eye care providers and health plan partners, announced during the 2017 ... the organization’s success enhancing care coordination for diabetic patients and integrating eye ...
(Date:2/19/2017)... ... February 19, 2017 , ... ... result in better care, and MEDfx and the Delaware Health Information Network (DHIN) ... , As the nation’s first state-wide health information exchange, DHIN stores and shares ...
(Date:2/18/2017)... Hills, California (PRWEB) , ... February 17, 2017 ... ... info@drvallecillos.com , drvallecillos.com , Beverly Hills plastic surgeon Dr. ... subcutaneous fat cells. , Dr. Vallecillos says, "Traditionally, plastic surgery has been centered ...
(Date:2/17/2017)... ... February 17, 2017 , ... While ... Enovate Medical has introduced an innovative workstation designed to reduce nursing fatigue while ... Encore Mobile EHR Workstation offers a lightweight, highly mobile, multi-functional alternative to the ...
Breaking Medicine News(10 mins):
(Date:2/20/2017)... Acute, Chronic and Prophylaxis GVHD The global graft versus host ... 2016-2021 and CAGR of 3% from 2021-2027. The market is expected to ... is estimated at $0.36bn in 2016, $0.51bn in 2021, and $0.64bn in ... How this report will ... future business opportunities emerging in this sector. In this brand ...
(Date:2/19/2017)...  nThrive™, an independent Patient-to-Payment? solutions company will ... at the 2017 HIMSS Conference. The company will ... KLAS. nThrive will host a Lunch ... trends shape the holistic, integrated revenue cycle of ... Access solution. The panel will reveal how health ...
(Date:2/19/2017)... and ORLANDO, Fla. , Feb. ... NKTR ) today announced that positive Phase 1 clinical ... with renal cell carcinoma (RCC) were presented at ASCO ... to expand specific cancer-fighting T cells and Natural Killer ... increase expression of PD-1 on these immune cells.  The ...
Breaking Medicine Technology: